Related Experiment Video

Updated: Oct 13, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Treatment of hyperkalemia in children with intravenous salbutamol

A Noyan1, A Anarat, M Pirti

  • 1Cukurova University School of Medicine, Department of Pediatric Nephrology, Adana, Turkey.

Acta Paediatrica Japonica : Overseas Edition
|June 1, 1995
PubMed

Insights

Intravenous salbutamol effectively lowers high potassium levels in children with kidney failure. This treatment offers a safe and significant reduction in plasma potassium concentrations.

Area of Science:

  • Pediatric Nephrology
  • Clinical Pharmacology
  • Emergency Medicine

Background:

  • Hyperkalemia is a serious complication in children with acute or chronic renal failure.
  • Effective and rapid management of hyperkalemia is crucial to prevent life-threatening cardiac arrhythmias.

Purpose of the Study:

  • To evaluate the efficacy and safety of intravenous salbutamol for treating hyperkalemia in pediatric patients with renal failure.
  • To assess the impact of salbutamol on plasma potassium levels in this vulnerable population.

Main Methods:

  • A cohort of 17 children (14 chronic renal failure, 3 acute renal failure) with hyperkalemia was treated.
  • Intravenous infusions of salbutamol at a dose of 4 micrograms/kg were administered.
  • Plasma potassium (K+) concentrations were measured before and at intervals after treatment.

Main Results:

  • A statistically significant reduction in mean plasma potassium levels was observed between 40 to 120 minutes post-therapy (P < 0.01).
  • Intravenous salbutamol demonstrated efficacy in lowering potassium levels in children with renal failure.

Conclusions:

  • Intravenous salbutamol is an effective therapeutic option for managing hyperkalemia in pediatric patients with renal failure.
  • The study supports the use of salbutamol as a safe and effective treatment for reducing elevated potassium levels in this clinical setting.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Antiarrhythmic Drugs: Class II Agents as &#946;-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiasthma Drugs: &#946;2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...